An ADC's Path to Market-Analysis of Difficulties and Key Points in ADC Process Scale up-Case Studies & Whitepapers-End-to-end CDMO | Porton Pharma Solutions

Case Studies & Whitepapers2025-03-24

Drug discovery is an exceedingly complex process. Discovering a new chemical entity is in itself a huge accomplishment, which is often possible only after almost two decades of hard experimental work as well as advanced simulation efforts. Therefore, the next stage of the process, determination of toxicity becomes even more crucial as most new chemical entities (NCE) are disqualified if the NCE shows a potential toxic effect, despite any possible therapeutic effect.

Case Studies & Whitepapers2025-03-13

The PROTAC technology, through an innovative mechanism of "degradation rather than inhibition," provides a new pathway for targeting traditionally undruggable proteins and addressing resistance issues.